Lupin appoints Mark D. McDade as an Independent Director

Lupin has announced Appointment of New Independent Director effective January 28, 2021

Feb 02, 2021 11:02 IST India Infoline News Service

Lupin
Lupin Limited, global pharmaceutical company has announced the appointment of Mark D. McDade as an Independent Director effective January 28, 2021.

McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years, he has led and transformed global companies as well as founded and advanced Biotech companies.

Commenting on the appointment, Manju D. Gupta, Chairman, Lupin said, “We are delighted to welcome Mr. Mark D. McDade on Lupin’s board. We are confident that his diverse experience across large, mid and development-stage companies across Specialty & Biologics, will help advance our growth journey.”

McDade holds a B.A. in History from Dartmouth College and MBA from Harvard Business School. 

Lupin Ltd is currently trading at Rs1,007 apiece up by Rs18.70 or 1.94% from its previous closing of Rs988.30 on the BSE, at around 12pm.

Related Story

Open Free Demat Account (Rs699)
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity